These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32882108)
1. Reduction in environmental noise during COVID-19 pandemic and cardiovascular disease: A mystery for further investigation. Antza C; Stabouli S J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1947-1948. PubMed ID: 32882108 [No Abstract] [Full Text] [Related]
2. Impact of the COVID‑19 pandemic on blood pressure control and cardiovascular risk profile in patients with hypertension. Januszewicz A; Wojciechowska W; Prejbisz A; Dobrowolski P; Rajzer M; Kreutz R Pol Arch Intern Med; 2021 Oct; 131(10):. PubMed ID: 34704702 [No Abstract] [Full Text] [Related]
4. Telemedicine in Cardiology for Outpatient Follow-Up of Patients at High Cardiovascular Risk in Response to the COVID-19 Pandemic. Moreira HT; Volpe GJ; Rezek UC; Mendonça PC; Teixeira GCA; Santos BMD; Olivieri APG; Chierice AJA; Monteiro HZ; Araújo NM; Maciel BC; Pazin Filho A; Schmidt A Arq Bras Cardiol; 2021 Jan; 116(1):153-157. PubMed ID: 33566981 [No Abstract] [Full Text] [Related]
5. The COVID-19 pandemic: lifestyle and cardiovascular risk factors. Bhatnagar D Curr Opin Lipidol; 2021 Feb; 32(1):71-73. PubMed ID: 33315619 [No Abstract] [Full Text] [Related]
6. Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic. Narita K; Hoshide S; Tsoi K; Siddique S; Shin J; Chia YC; Tay JC; Teo BW; Turana Y; Chen CH; Cheng HM; Sogunuru GP; Wang TD; Wang JG; Kario K J Clin Hypertens (Greenwich); 2021 Mar; 23(3):575-583. PubMed ID: 33527663 [TBL] [Abstract][Full Text] [Related]
7. The Burden of Cardiovascular Disease in the Post-COVID Era. Liu J; Cepeda M; Frangaj B; Shimbo D Prim Care; 2024 Mar; 51(1):1-11. PubMed ID: 38278564 [TBL] [Abstract][Full Text] [Related]
8. [COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations]. Pallarés-Carratalá V; Polo García J; Martín Rioboo E; Ruíz García A; Serrano-Cumplido A; Barrios V; Semergen; 2021; 47(1):1-3. PubMed ID: 33478841 [No Abstract] [Full Text] [Related]
9. Editorial commentary: COVID-19 as a cardiovascular disease risk factor. Oktay AA; Suboc TM; Volgman AS Trends Cardiovasc Med; 2022 Nov; 32(8):476-478. PubMed ID: 35850405 [No Abstract] [Full Text] [Related]
10. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature. Rahimi L; Malek M; Ismail-Beigi F; Khamseh ME Adv Ther; 2020 Aug; 37(8):3450-3462. PubMed ID: 32632851 [TBL] [Abstract][Full Text] [Related]
11. Heartbeat: an increase in preventable cardiovascular deaths during the COVID-19 pandemic due to avoidance of medical care. Otto CM Heart; 2021 Jan; 107(2):89-90. PubMed ID: 33443018 [No Abstract] [Full Text] [Related]
12. Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease. Savedchuk S; Raslan R; Nystrom S; Sparks MA Circ Res; 2022 May; 130(10):1618-1641. PubMed ID: 35549373 [TBL] [Abstract][Full Text] [Related]
13. Avoidable Cardiovascular Events: A Serious Side Effect of the COVID-19 Pandemic. Cesena FHY Arq Bras Cardiol; 2021 Mar; 116(3):381-382. PubMed ID: 33909763 [No Abstract] [Full Text] [Related]
14. Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention. Volpe M; Battistoni A; ; Bellotti P; Bellone S; Bertolotti M; Biffi A; Consoli A; Corsini A; Desideri G; Ferri C; Modena MG; Nati G; Pirro M; Rubattu S; Tocci G; Trimarco B; Volpe R; de Kreutzenberg SV High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):373-377. PubMed ID: 32734561 [TBL] [Abstract][Full Text] [Related]
15. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. Kreutz R; Dobrowolski P; Prejbisz A; Algharably EAE; Bilo G; Creutzig F; Grassi G; Kotsis V; Lovic D; Lurbe E; Modesti PA; Pappaccogli M; Parati G; Persu A; Polonia J; Rajzer M; de Timary P; Weber T; Weisser B; Tsioufis K; Mancia G; Januszewicz A; J Hypertens; 2021 Jun; 39(6):1077-1089. PubMed ID: 33395152 [TBL] [Abstract][Full Text] [Related]
16. Aspirin Use for Primary Cardiovascular Prevention During the COVID-19 Pandemic. Siegel AJ Am J Med; 2021 Apr; 134(4):e299. PubMed ID: 33888225 [No Abstract] [Full Text] [Related]
17. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review. Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Risk Factors Among Patients Infected with COVID-19 in Saudi Arabia. Alshaikh MK; Alotair H; Alnajjar F; Sharaf H; Alhafi B; Alashgar L; Aljuaid M Vasc Health Risk Manag; 2021; 17():161-168. PubMed ID: 33907410 [TBL] [Abstract][Full Text] [Related]